Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Surveying Patients' Experiences and Perspectives on Venous Thromboembolism Care: An International Study to Identify Gaps and Opportunities in Health Care Delivery

Rushad Patell, Laura Dodge, Ang Li, Anna L Parks, Jordan K Schaefer, Alejandra Gutierrez Bernal, Shruti Chaturvedi, Anjlee Mahajan, Jori E. May, William Robertson, Leslie Lake, Dana E. Angelini

Blood (2023) 142 (Supplement 1): 5043.

https://doi.org/10.1182/blood-2023-181172

Published: 2023

Journal Articles

Estimating the Burden of Venous and Arterial Thrombotic Events in Hospitalized Adults with COVID-19; A National Multicenter Cohort Study

Rushad Patell, Dana E. Angelini, Stacy R Ellsworth, Paul Lewis, James C Lee, Edith A. Nutescu, Alpesh Amin, Daniel M Witt, Marisol Betensky, Neil Goldenberg, Peter Kouides, Doaa Attia, MD, Lyla Mourany, Leslie Lake, Rachel P. Rosovsky, Alok A. Khorana, Scott Kaatz

Blood (2023) 142 (Supplement 1): 1262.

https://doi.org/10.1182/blood-2023-187029

Published: 2023

Journal Articles

Improving Patient Access and Provider Availability in Classical Hematology: The Development of an Advanced Practice Provider Led Virtual Anemia Consult Clinic

Mailey L. Wilks, Heather Koniarczyk, Dana E. Angelini, Laurie Aiken, Peter E. Hakos, Tracy Evans-Walker, Keith R. McCrae

Blood (2023) 142 (Supplement 1): 2298.

https://doi.org/10.1182/blood-2023-181967

Published: 2023

Journal Articles

Managing Kidney Disease in Patients with Sickle Cell Disease: A Quality Initiative at the Cleveland Clinic

Anne K Hubben, Dana E. Angelini, Sandra Mazzoni

Blood (2022) 140 (Supplement 1): 10755.

https://doi.org/10.1182/blood-2022-169894

Published: 2022

Journal Articles

Safety and Efficacy of Continuous Use Avatrombopag in Chronic Liver Disease

Sandra Mazzoni, Dana E. Angelini

Blood (2022) 140 (Supplement 1): 11236–11237.

https://doi.org/10.1182/blood-2022-165753

Published: 2022

Journal Articles

Multicenter, Randomized Crossover Trial Comparing Recombinant Von Willebrand Factor and Tranexamic Acid for Heavy Menstrual Bleeding in Von Willebrand Disease

Blood (2022) 140 (Supplement 1): 1413–1415.

https://doi.org/10.1182/blood-2022-156921

Published: 2022

Journal Articles

Efficacy of the Hepcon System in Reducing Hemorrhagic and Thrombotic Complications in Antiphospholipid Syndrome Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass

Michael Sheu, Wei Wei, Lauren M Granat, John Apostolakis, Patrick M Grady, Dana E. Angelini

Blood (2022) 140 (Supplement 1): 2821–2822.

https://doi.org/10.1182/blood-2022-167029

Published: 2022

Journal Articles

Risk of Venous Thromboembolism and Survival Outcomes in Patients with Lymphoma

Doaa Attia, Wei Wei, Mailey L. Wilks, Christopher D'Andrea, Alok A Khorana, Dana E. Angelini

Blood (2021) 138 (Supplement 1): 4262.

https://doi.org/10.1182/blood-2021-152321

Published: 2021

Journal Articles

Venous Thromboembolism Is Associated with Inferior Survival after Allogeneic Hematopoietic Cell Transplant

Lauren M. Granat, Lisa A. Rybicki, Mailey L. Wilks, Christina Ferraro, Matt Kalaycio, Ronald M. Sobecks, Navneet S. Majhail, Dana E. Angelini, Betty K. Hamilton

Blood (2021) 138 (Supplement 1): 4866.

https://doi.org/10.1182/blood-2021-151230

Published: 2021

Journal Articles

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-136101

Published: 2020

Journal Articles

Thromboembolism in Patients with Advanced Renal Cell Carcinoma Treated with Immunotherapy

Iris Yeong- Fung Sheng, MD, Shilpa Gupta, MD, Chandana A Reddy, MS, Dana E Angelini, MD, Pauline Funchain, MD, Joanna Roopkumar, MBBS, MPH, Tamara A. Sussman, MD, Joseph Sleiman, MD, Timothy D Gilligan, MD, Moshe C Ornstein, MD MA, Alok A Khorana, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-137140

Published: 2020

Journal Articles

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-142805

Published: 2020

Journal Articles

Bleeding Outcomes of Gastrointestinal Cancer Patients Treated with Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin

Dana E Angelini, MD, Doaa Attia, MD, Wei Wei, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD

Blood (2020) 136 (Supplement 1): 27.

https://doi.org/10.1182/blood-2020-136757

Published: 2020

Journal Articles

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Fahrettin Covut, MD, Ramsha Ahmed, MD, Christy J. Samaras, DO, Faiz Anwer, MD, Alex V. Mejia Garcia, MD, Dana E Angelini, MD, Beth M. Faiman, PhDCNP, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Saveta Mathur, CNP, Kimberly Hamilton, APRN/PA, Nathaniel Rosko, PharmD, Jason Valent, MD, Jack Khouri, MD

Blood (2019) 134 (Supplement_1): 3148.

https://doi.org/10.1182/blood-2019-131400

Published: 2019

Journal Articles

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

Shyam K Poudel, Chandana A Reddy, MS, Deborah Y Park, BS, Mailey L Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, Jung-Min Song, RN,CNS, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2019) 134 (Supplement_1): 3458.

https://doi.org/10.1182/blood-2019-127581

Published: 2019

Journal Articles

Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis

Mailey L Wilks, MSN, APRN, NP-C, Shyam K. Poudel, MD, Deborah Y. Park, BS, Xuefei Jia, MS, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barb Tripp, CNS, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Alok A. Khorana, MD, Dana E. Angelini, MD

Blood (2018) 132 (Supplement 1): 3570.

https://doi.org/10.1182/blood-2018-99-117338

Published: 2018

Journal Articles

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Deborah Y. Park, BS, Shyam K. Poudel, MD, Xuefei Jia, MS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS,AOCN, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Dana E. Angelini, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2018-99-111897

Published: 2018

Journal Articles

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

Shyam K. Poudel, MD, Xuefei Jia, MS, Deborah Y. Park, BS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, AOCN, Jung-Min Song, RN, CNS, Keith R. McCrae, MD, Alok A. Khorana, MD, Dana E. Angelini, MD

Blood (2018) 132 (Supplement 1): 4809.

https://doi.org/10.1182/blood-2018-99-114897

Published: 2018

Journal Articles

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

Girish Kunapareddy, MD, Benjamin Switzer, DO, MHSA, MS, Madison Conces, MD, Pramod Pinnamaneni, MD, Bhumika J. Patel, MD, Sagar S. Patel, MD, Alicia Redden, Dana E. Angelini, MD, Keith McCrae, MD, Brad Pohlman, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 3361.

https://doi.org/10.1182/blood.V130.Suppl_1.3361.3361

Published: 2017

Journal Articles

Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience

Shafia Rahman, Dana E. Angelini, MD, Paul Elson, PhD, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barb Tripp, CNS,AOCN, Jung- Min Song, RN,CNS, Keith McCrae, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 4633.

https://doi.org/10.1182/blood.V130.Suppl_1.4633.4633

Published: 2017

NARROW

Surveying Patients' Experiences and Perspectives on Venous Thromboembolism Care: An International Study to Identify Gaps and Opportunities in Health Care Delivery

Estimating the Burden of Venous and Arterial Thrombotic Events in Hospitalized Adults with COVID-19; A National Multicenter Cohort Study

Improving Patient Access and Provider Availability in Classical Hematology: The Development of an Advanced Practice Provider Led Virtual Anemia Consult Clinic

Managing Kidney Disease in Patients with Sickle Cell Disease: A Quality Initiative at the Cleveland Clinic

Safety and Efficacy of Continuous Use Avatrombopag in Chronic Liver Disease

Multicenter, Randomized Crossover Trial Comparing Recombinant Von Willebrand Factor and Tranexamic Acid for Heavy Menstrual Bleeding in Von Willebrand Disease

Efficacy of the Hepcon System in Reducing Hemorrhagic and Thrombotic Complications in Antiphospholipid Syndrome Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass

Risk of Venous Thromboembolism and Survival Outcomes in Patients with Lymphoma

Venous Thromboembolism Is Associated with Inferior Survival after Allogeneic Hematopoietic Cell Transplant

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Thromboembolism in Patients with Advanced Renal Cell Carcinoma Treated with Immunotherapy

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Bleeding Outcomes of Gastrointestinal Cancer Patients Treated with Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only